AnalystsCerena ChenCerena Chen's Stock Forecasts
AnalystsCerena Chen
Analyst Ranking
Top 37%
#1877 out of 5150 analysts
Average Return
+44.63%
Win Rate
100%5 out of 5
Risk vs Reward
Poor
Good
Cerena Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Metsera IncMTSR | +138.18% | $29.60 | $70.50 | 2025-06-19 - 2025-11-14 | Strong Buy |
Axsome Therapeutics IncAXSM | +37.72% | $89.65 | $123.47 | 2024-09-02 - 2025-09-02 | Strong Buy |
Axsome Therapeutics IncAXSM | +32.11% | $112.16 | $148.17 | 2025-05-05 - 2025-12-12 | Strong Buy |
Axsome Therapeutics IncAXSM | +12.63% | $131.55 | $148.17 | 2025-02-11 - 2025-12-12 | Strong Buy |
Amphastar Pharmaceuticals IncAMPH | +2.52% | $24.65 | $25.27 | 2025-05-07 - 2025-12-12 | Strong Buy |
Cerena Chen Analyst Color
Get additional color on Cerena Chen's coverage of popular stocks
Cerena Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Strategy IncMSTR | 1 | Hold | $54.00 | -69.40% | Downgrades | 2 months ago |
Metsera IncMTSR | 1 | Strong Buy | $65.00 | -7.80% | Initiates Coverage On | 6 months ago |
Amphastar Pharmaceuticals IncAMPH | 1 | Strong Buy | $35.00 | +38.50% | Maintains | 7 months ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $165.00 | +11.36% | Maintains | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.